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CORRECTION
Correction: A specific expression profile of
LC3B and p62 is associated with nonresponse
to neoadjuvant chemotherapy in esophageal
adenocarcinomas
Olivia Adams, Fe´lice A. Janser, Bastian Dislich, Sabina Berezowska, Magali Humbert,
Christian A. Seiler, Dino Kro¨ll, Julia Slotta-Huspenina, Marcus Feith, Katja Ott, Mario
P. Tschan, Rupert Langer
The seventh author’s name is spelled incorrectly. The correct name is: Dino Kro¨ll.
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